Agios Pharm
Biotechnology
Healthcare
AGIO
58.43 M shares
NASDAQ US
traded
09 Apr 2025
listed
no
open
24.04
52 week high
61.64
high
27.08
52 week low
24.53
low
23.42
growth
-27.68 %
previous Close
24.53
P/E ratio
-11
market cap
2.02 B
div yield
0
usd
Sep 2024
qoq
revenue
8.96 M
4.05 %
net incoming
948 M
1.00 %
eps
-2.42 %
-43.20 %
eps surprise
-318.02 %
net profit margin
10574.69 %
11690.00 %
operating incoming
-102.81 M
2.84 %
net change in cash
169 M
594.11 %
cash on hand
254 M
200.21 %
cost of revenue
783 K
-74.64 %
top top